Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Aluminum – calcium or magnesium element – or compound containing
Patent
1998-12-15
2000-08-08
Harrison, Robert H.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Aluminum, calcium or magnesium element, or compound containing
514711, 562104, A61K 31095, A61K 31195
Patent
active
060998695
ABSTRACT:
Use of calcium taurate as an antihypertensive agent and dietary supplement. The compound is prepared by reacting taurine and calcium in a 2:1 molar ratio. The resulting mixture is diluted with alcohol and the remaining clear filtrate is crystallized. Calcium taurate is taken orally as nutritional supplement or antihypertensive agent, and can be used as an adjuvant to conventional antihypertensive drugs.
REFERENCES:
patent: 4199601 (1980-04-01), Durlach
patent: 4267194 (1981-05-01), Durlach
patent: 4521619 (1985-06-01), Kaplan
patent: 5582829 (1996-12-01), McCarty
Dolara et al. Taurine-Calcium Interaction Measured by Means of 13C Nuclear Magnetic Resonance. Short Communication in: Biochemical Pharmacology, vol. 27. (1978) pp. 803-804.
Irving et al. 13C Nuclear Magnetic Resonance Study of ther Complexation of Calcium by Taurine. J. of Inorganic Biochemistry, vol. 13, pp. 137-150, (1980).
T.W. Anderson, et al. (1975) Ischemic heart disease, water hardness and myocardial magnesium. CMA Journal 113:199-203.
S.E. Atahanov, et al. (1992) Modulation of receptor-dependent increase of calcium ions in human platelets by taurine. Arzneim. -Forsch./Drug Res. 42(II):1311-1313.
J. Azuma, et al. (1983) Double-blind randomized crossover trial of taurine in congestive heart failure. Current Therapeutic Res. 34(4):543-557.
T.G. Brott, et al. (1992) Urgent therapy for stroke, Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23:632-640.
B.S. Coller (1990) Platelets and thrombolytic therapy. The New England Journal Of Medicine 322(1):33-42.
T. Dyckner, et al. (1983) Effect of magnesium on blood pressure. British Medical Journal 286:1847-1849.
H.J. Gelmers, et al. (1988) A controlled trial of nimodipine in acute ischemic stroke. The New England Jouranl Of Medicine 318(4):203-207.
W. Hacke, et al. (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19(10):1216-1222.
K.C. Hayes, et al. (1989) Taurine modulates platelet aggregation in cats and human. Am. J. Clin. Nutr. 49:1211-1216.
R.J. Huxtable (1992) Physiological actions of taurine. Physiological Reviews 72(1):101-163.
L.T. Iseri (1984) Magnesium in coronary artery disease. Drugs 28(Suppl. 1):151-160.
M. Malcangio, et al. (1989) Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia. Psychopharmacology 98:316-320.
T. Motoyama, et al. (1989) Oral magnesium supplementation in patients with essential hypertension. Hypertension 13:227-232.
A. Puca (1993) Thrombolysis in cerebral ischemia. A review of clinical and experimental data. Journal Neurosurg. Science 37:63-70.
S.M. Rothman (1983) Synaptic activity mediates death of hypoxic neurons. Science 220:536-537.
M.P. Ryan, et al. (1984) The role of magnesium in the prevention and control of hypertension. Ann. Clin. Res. 16:82-88.
S.W. Schaffer, et al. (1990) Regulation of calcuim homeostasis by taurine: role of calmodulin. Taurine: Functional Neurochemistry, Physiology, and Cardiology 217-225.
S.W. Schaffer, et al. (1994) Mechanisms underlying physiological and pharmacological actions of taurine on myocardial calcium transport. Taurine in Health and Disease 171-180.
A. Schurr, et al. (1987) Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sciences 40:2059-2066.
M.S. Seelig, et al. (1974) Magnesium interrelationships in ischemic heart disease: a review. The American Journal of Clinical Nutrition 27: 59-79.
M. Shechter, et al. (1992) The rationale of magensium supplementation in acute myocardial infarction. Arch Intern. Med. 152:2189-2196.
Trust Study Group (1990) Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. The Lancet 336;1205-1209.
B.C. White, et al. (1984) Brian ischemic anoxia. JAMA 251(12):1586-1590.
M.C.W. Wong, et al. (1990) Calcium antagonists: stroke therapy coming of age. Stroke 21(3):494-501.
Harrison Robert H.
Nutrition 21
LandOfFree
Calcium taurate and antihypertensive drug for hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium taurate and antihypertensive drug for hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium taurate and antihypertensive drug for hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1147850